Laser Capture Microdissection Market is Appraised to be Valued US$ 143 million by 2022

Laser Capture Microdissection Market to Reach US$ 143 million value by the end of 2022.
Adoption of advanced molecular imaging techniques such as laser capture microdissection (LCM)
continues to gain traction in the global life sciences industry. Independent scientists and medical
research organizations from around the world are actively using LCM systems to procure selected
human cell populations from heterogeneous, complex human tissues. Under direct microscopic
visualization, laser capture microdissections have been highly effective both, as an imaging method
and an analytical tool, in the field of histopathology and molecular biology.
A recent market study published by Persistence Market Research reveals that the global market for
laser capture microdissection will witness a robust growth at a CAGR of 10.2% during the forecast
period, 2017-2022. As the technique offers selective procurement of targeted cells, with a strong
focal adhesion, the adoption of laser capture microdissection is expected to propel vigorously in the
near future. Towards the end of 2022, the global laser capture microdissection market is anticipated
to reach US$ 143 million in value.
Request for Table of Contents @ https://www.persistencemarketresearch.com/marketresearch/laser-capture-microdissection-market/toc
The study projects that academic institutes will be the largest end-users of laser capture
microdissection in 2017, and will account for nearly three-fifth share of the estimated global market
value. Key role of laser capture microdissection in cancer research studies, particularly in
monitoring the molecular progression of cancerous cells and tissues will propel their use in
academic institutes. These institutes will also showcase higher adoption of laser capture
microdissection in comparison studies, wherein LCM techniques will be used for identifying
genetic differences between normal tissues, preneoplastic tissues, and cancer tissues. Likewise, the
end-use of laser capture microdissection in pharmaceutical & biotech companies, and hospitals will
also gain traction through 2022.
North America to represent largest market for laser capture microdissection :A regional analysis
offered in the report reveals that North America’s laser capture microdissection market will soar
vigorously at a CAGR of 10.6% over the forecast period. Robust healthcare infrastructure in the
US, coupled with extensive funding for medical research projects, will continue to fuel the adoption
of laser capture microdissection in North America. The laser capture microdissection market in
Europe and Japan, on the other hand, will represent growth at close-matched CAGRs. Due to low
penetration of medical research initiatives and biotechnologies, the laser capture microdissection
market in the Asia-Pacific excluding Japan (APEJ) region will reach a little over US$ 18 million
value by the end of 2022.
Request to View Sample of Research Report @
https://www.persistencemarketresearch.com/samples/18628
Changing competitive landscapes of healthcare and biotechnology markets are less likely to extend
their influence in the global laser capture microdissection market. Currently, the global laser capture
microdissection market is niche with respect to active participation of companies. Over the next five
years, Thermo Fisher Scientific Inc., Carl Zeiss AG, Danaher Corporation, Theranostics Health Inc.,
Molecular Machines & Industries, Ocimum Biosolutions LLC, AvanSci Bio LLC, and
3DHISTECH Ltd. will be observed as key players in the global laser capture microdissection
market. Majority of these companies are likely to focus on developing LCM systems for cancer
research applications. Moreover, some companies are also expected to enhance the effectiveness of
immunofluorescence laser capture microdissection systems.

Laser Capture Microdissection Market is Appraised to be Valued US$ 143 million by 2022

Download Report